H.C. Wainwright Reiterates Buy Rating on Novavax (NVAX)

December 11, 2024 7:22 AM UTC Send to a Friend
H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating and $19.00 price target on Novavax (NASDAQ: NVAX).The analyst commented: "On ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login